Reletter
Artwork for Polypharmacy

Polypharmacy

Nils Wendel, MD

Rationalist-adjacent musings on things we do in psychiatry

Platform
Substack
PricingOnly free issuesPublishesWeekly
Issues12SubscribersRead polypharmacy.substack.com

Curious about how many subscribers Polypharmacy has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over one million newsletters.

Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.

Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.

Contact Information
How Many Subscribers?
Reletter gives you subscriber numbers, contacts, chart rankings, traffic estimates and more across 1.6m+ newsletters.

Latest Issues

Recent posts by this newsletter. Browse the email archive.

Reconsidering Dopamine

Sometimes I forget about the two years of my college education that I spent doing nothing but thinking about neurobiology. There’s a vague sense in psychiatry that we’re supposed to know about the basic science aspects of the brain, but in ...

15 days ago
25
3

Wot's Uh... The Deal With How We Pick Antidepressants and Antipsychotics Pt. 2

This is the second part of an essay about the selection of antidopaminergics and antidepressants. In Part I, I outlined (what I see as) the prevailing attitude of psychiatrists towards their selection of antidepressants and antidopaminergic...

2 months ago
29
11

Wot's Uh... The Deal With How We Pick Antidepressants and Antipsychotics Pt. 1

I’ve been neglecting the antidepressants.

2 months ago
21
15

Impressions from the 2024 American Psychiatric Conference

I went to the American Psychiatric Association’s (APA) conference in NYC this weekend, and because I’m still wrestling with my next deep-dive psychopharm piece, I decided to write down my impressions of the conference. This was the first AP...

3 months ago
8
2

Authors

The writers behind this newsletter.

  • Nils Wendel, MD

    Psychiatric resident, independently minded to a troublesome degree. Occasionally produces original thoughts worth sharing.

  • Frequently Asked Questions

    How can I access the email archive for Polypharmacy?

    You can find recent issues that have been published by Polypharmacy on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.

    How many subscribers does Polypharmacy have?

    To see how many people subscribe to Polypharmacy, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.

    How can I advertise in Polypharmacy?

    Newsletter advertising can be extremely effective when it's done right. Before you pitch Polypharmacy as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.

    Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.

    How much does it cost to sponsor a publication like Polypharmacy?

    Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.

    To find out how much an ad will cost, contact Polypharmacy using the contact information provided and ask for a copy of their media kit.

    How can I find newsletters similar to Polypharmacy?

    Scroll up to where it says Similar Newsletters to see other publications like Polypharmacy. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.

    How do I contact Polypharmacy?

    Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.